SEC 13F Intelligence

Managers / Q4 2023 · view latest →

Hillcrest Wealth Advisors - NY, LLC

CIK 0001767121 · 100 VILLAGE COURT, SUITE 202, HAZLET, NJ, 07730 · 732.837.4455

Reported Value
$181M
Q4 2023
Positions
45
Filings on Record
30
2019–present window
Filed
Jan 12, 2024
original filing

Summary

Hillcrest Wealth Advisors - Ny, LLC reported $181M in U.S.-listed holdings across 45 positions for Q4 2023.

The portfolio is heavily concentrated: IWM alone accounts for 37.4% of reported value.

Compared with Q3 2023, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+4.6%
vs prior filed quarter
Top-10 Concentration
+95.3%
share of reported value
Largest Position
+37.4%
Ishares Tr

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $108MQ4 ’18Q1 ’19: $114MQ2 ’19: $119MQ3 ’19: $116MQ4 ’19: $120MQ4 ’19Q1 ’20: $100MQ2 ’20: $116MQ3 ’20: $141MQ4 ’20: $149MQ4 ’20Q1 ’21: $164MQ2 ’21: $165MQ3 ’21: $169MQ4 ’21: $186MQ4 ’21Q1 ’22: $181MQ2 ’22: $165MQ3 ’22: $158MQ4 ’22: $167MQ4 ’22Q1 ’23: $169MQ2 ’23: $169MQ3 ’23: $176MQ4 ’23: $181MQ4 ’23Q1 ’24: $185MQ2 ’24: $186MQ3 ’24: $200MQ4 ’24: $210MQ4 ’24Q1 ’25: $202MQ2 ’25: $213MQ3 ’25: $222MQ4 ’25: $232MQ4 ’25Q1 ’26: $247Mfilingsflow.com

Portfolio Composition

By security type
ETP: 95.3%Common Stock: 4.5%REIT: 0.2%
  • ETP · 95.3% · $173M
  • Common Stock · 4.5% · $8M
  • REIT · 0.2% · $412,256

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SCHHSCHWAB STRATEGIC TRSOLD OUT−51.5K0−$913,238$0
ISHARES TRSOLD OUT−7.2K0−$530,784$0
XLFSELECT SECTOR SPDR TRTRIMMED−43.2K19.8K−$1M$742,600
XBISPDR SER TRTRIMMED−13.7K9.5K−$846,853$852,541
VGTVANGUARD WORLD FDSTRIMMED−1.2K1.2K−$423,605$592,900
FXIISHARES TRADDED+15.5K48.6K+$288,927$1M
VNQVANGUARD INDEX FDSTRIMMED−2.4K4.5K−$127,839$397,620
TIPISHARES TRTRIMMED−28.1K59.8K−$3M$6M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

22 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1IWMISHARES TRRUSSELL 2000 ETF · RUS 2000 VAL ETF · RUS 2000 GRW ETF · TIPS BD ETF · 0-5 YR TIPS ETF · RUS 1000 VAL ETF · CORE US AGGBD ET · RUS 1000 GRW ETF · RUS 1000 ETF · CHINA LG-CAP ETF · CORE S&P SCP ETF · MSCI EAFE ETF · MSCI EMG MKT ETF37.40%$68M478.0K
2VOOVANGUARD INDEX FDSS&P 500 ETF SHS · VALUE ETF · GROWTH ETF · REAL ESTATE ETF · TOTAL STK MKT26.85%$49M134.7K
3VEUVANGUARD INTL EQUITY INDEX FALLWRLD EX US · FTSE EMR MKT ETF9.58%$17M342.8K
4SPYSPDR S&P 500 ETF TRhistory →TR UNIT6.53%$12M24.9K
5VEAVANGUARD TAX-MANAGED FDShistory →VAN FTSE DEV MKT5.56%$10M210.8K
6SDYSPDR SER TRS&P DIVID ETF · BLOOMBERG HIGH Y · S&P BIOTECH2.61%$5M42.9K
7BRK/BBERKSHIRE HATHAWAY INC DELhistory →CL B NEW2.59%$5M13.2K
8XLVSELECT SECTOR SPDR TRSBI HEALTHCARE · FINANCIAL · INDL1.51%$3M35.2K
9DBX ETF TRXTRACK MSCI EAFE1.43%$3M70.2K
10VCITVANGUARD SCOTTSDALE FDShistory →INT-TERM CORP1.23%$2M27.6K
11BSVVANGUARD BD INDEX FDSSHORT TRM BOND · TOTAL BND MRKT1.18%$2M28.1K
12GPNGLOBAL PMTS INCCOM0.87%$2M12.4K
13VGTVANGUARD WORLD FDSINF TECH ETF · CONSUM STP ETF0.48%$879,3402.7K
14IEMGISHARES INCCORE MSCI EMKT0.48%$866,18317.1K
15JPMJPMORGAN CHASE & COCOM0.40%$733,1314.3K
16GLDSPDR GOLD TRGOLD SHS0.30%$535,2762.8K
17GOOGLALPHABET INCCAP STK CL A0.25%$452,8753.2K
18AREALEXANDRIA REAL ESTATE EQ INCOM0.23%$412,2563.3K
19AAPLAPPLE INCCOM0.20%$357,5281.9K
20MSFTMICROSOFT CORPCOM0.17%$308,353820
21SCHVSCHWAB STRATEGIC TRUS LCAP VA ETF0.14%$254,6263.6K
22ONCONOVA THERAPEUTICS INCCOM NEW0.01%$12,46916.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$247M51Apr 28, 202613F-HRchanges · EDGAR ↗
Q4 2025$232M52Jan 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$222M53Oct 20, 202513F-HRchanges · EDGAR ↗
Q2 2025$213M49Jul 22, 202513F-HRchanges · EDGAR ↗
Q1 2025$202M48Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$210M50Jan 21, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M47Oct 17, 202413F-HRchanges · EDGAR ↗
Q2 2024$186M47Jul 18, 202413F-HRchanges · EDGAR ↗
Q1 2024$185M46Apr 11, 202413F-HRchanges · EDGAR ↗
Q4 2023$181M45Jan 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$176M47Oct 17, 202313F-HRchanges · EDGAR ↗
Q2 2023$169M47Jul 31, 202313F-HRchanges · EDGAR ↗
Q1 2023$169M48May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$167M50Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$158M52Nov 3, 202213F-HRchanges · EDGAR ↗
Q2 2022$165M50Aug 2, 202213F-HRchanges · EDGAR ↗
Q1 2022$181M48May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$186M52Feb 4, 202213F-HRchanges · EDGAR ↗
Q3 2021$169M52Oct 26, 202113F-HRchanges · EDGAR ↗
Q2 2021$165M51Aug 3, 202113F-HRchanges · EDGAR ↗
Q1 2021$164M53Apr 28, 202113F-HRchanges · EDGAR ↗
Q4 2020$149M51Feb 3, 202113F-HRchanges · EDGAR ↗
Q3 2020$141M59Oct 21, 202013F-HRchanges · EDGAR ↗
Q2 2020$116M44Aug 3, 202013F-HRchanges · EDGAR ↗
Q1 2020$100M41Apr 28, 202013F-HRchanges · EDGAR ↗
Q4 2019$120M38Jan 30, 202013F-HRchanges · EDGAR ↗
Q3 2019$116M38Oct 17, 201913F-HRchanges · EDGAR ↗
Q2 2019$119M41Aug 6, 201913F-HRchanges · EDGAR ↗
Q1 2019$114M41May 10, 201913F-HRchanges · EDGAR ↗
Q4 2018$108M54Feb 8, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.